increased antimycobacterial activity of isoprodian ( isoniazid + prothionamide + dapsone ) may be due to ( i ) decreased mutation rate for inh resistance provoked in mycobacteria by dds ( in 2 of 3 strains tested ) ;
C0360390
antimycobacterial
C0022209
resistance